Coca-Cola executives remain unfazed by the decline in full-sugar soft drink consumption among users of GLP-1 drugs, which suppress appetite.
Instead, the company is focusing on boosting sales of low- and no-calorie options and high-protein beverages through increased marketing and production efforts.
Coca-Cola Co. executives appear unperturbed by a drop in consumption of full-sugar soft drinks by the rising number of consumers on appetite-suppressing GLP-1 drugs.
Despite a challenging economic environment, where lower-income groups are reducing spending and health-conscious consumers are opting for non-sugar sweetened beverages, Coca-Cola is adapting its strategy.
Author's summary: Coca-Cola shifts focus to low-calorie and protein drinks.